The 2020 Story
The awards ceremony at the 2020 World ADC Digital event was unique and first of its kind, delivered through video. However, everyone’s involvement, collaboration and energy made the virtual experience just as enjoyable!
The 7th annual World ADC Awards showcased the innovation, leadership and devotion shown by the best companies, teams and individuals in the industry.
Across 9 categories the Awards recognized the extraordinary endeavors, teamwork and commercial acumen that has propelled the field to the forefront of cancer research today.
The finalists and winners were shortlisted from over 1000 votes cast and scientific proposals from each submission were evaluated by our Judging panel.
This year, given the exciting developments in the field, we are looking forward to the 8th Annual World ADC Awards ceremony taking place virtually on Tuesday, October 12.
The 2021 Shortlist:
Best ADC Platform Technology
Ajinomoto Biopharma Services
Araris Biotech AG
Legochem Bio (Scaffold Based
Synaffix (GlycoConnect™ & Hy
Sutro Biopharma (cell-free exp
Best New Drug Developer
Macrogenics
DebioPharm
ABL Bio
Bolt Biotherapeutics
Silverback Therapeutics
Most Promising Clinical Candidate
Camidanlumab Tesirine (ADCT-301)
Trastuzumab duocarmazine (SYD985)
STRO-002
CX2029 (CytomX, CD71 PDC)
patritumab deruxtecan (HER3-DXd; formerly U3-1402
Best Contract Manufacturing (CMO) Provider
BSP Pharmaceuticals
Millipore Sigma
Wuxi Biologics
Ajinomoto Biopharma Services
Lonza
Best Contract Research (CRO) Provider
NJ Bio
Charles River
ADC Bio
Menarini
Covance
The 2020 Winners Are:
Best ADC Platform Technology
Synaffix – Winner
Legochem Bio – Runner Up
Best New Drug Developer
Sutro Biopharma – Winner
Mersana Therapeutics – Runner Up
Most Promising Clinical Candidate
DS-1062 (Daiichi Sankyo) – Winner
Loncastuximab Tesirine (ADC Therapeutics) – Runner Up
Best Contract Manufacturing (CMO) Provider
Piramal – Winner
BSP Pharmaceuticals – Runner Up
Best Contract Research (CRO) Provider
Abzena – Winner
NJ Biopharmaceuticals – Runner Up
Best Pre-Clinical Publication
Winner:
Czechowicz A, Palchaudhuri R, Scheck A, Hu Y, Hoggatt J, Saez B, Pang WW, Mansour MK, Tate TA, Chan YY, Walck E, Wernig G, Shizuru JA, Winau F, Scadden DT, Rossi DJ.Nat Commun. 2019 Feb 6;10(1):617. doi: 10.1038/s41467-018-08201-x.
Winner:
AJICAP: Affinity Peptide Mediated Regiodivergent Functionalization of Native Antibodies.
Yamada K, Shikida N, Shimbo K, Ito Y, Khedri Z, Matsuda Y, Mendelsohn BA.Angew Chem Int Ed Engl. 2019 Apr 16;58(17):5592-5597. doi: 10.1002/anie.201814215. Epub 2019 Mar 29.
Best Clinical Publication
Winner:
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, Wülfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE Jr; KATHERINE Investigators.N Engl J Med. 2019 Feb 14;380(7):617-628. doi: 10.1056/NEJMoa1814017.
Individual Input to the Field 2019
Aldo Braca (BSP Pharmaceuticals)
Long Standing Contribution to the Field
Rakesh Dixit
WORLD ADC SERIES
